BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chia J, Goh G, Bard F. Short O-GalNAc glycans: regulation and role in tumor development and clinical perspectives. Biochim Biophys Acta 2016;1860:1623-39. [PMID: 26968459 DOI: 10.1016/j.bbagen.2016.03.008] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Ronan R, Kshirsagar A, Rebelo AL, Sunny A, Kilcoyne M, Flaherty RO, Rudd PM, Schlosser G, Saldova R, Pandit A, McMahon SS. Distinct Glycosylation Responses to Spinal Cord Injury in Regenerative and Nonregenerative Models. J Proteome Res 2022. [PMID: 35506863 DOI: 10.1021/acs.jproteome.2c00043] [Reference Citation Analysis]
2 Xu Z, Zhang Y, Ocansey DKW, Wang B, Mao F. Glycosylation in Cervical Cancer: New Insights and Clinical Implications. Front Oncol 2021;11:706862. [PMID: 34485140 DOI: 10.3389/fonc.2021.706862] [Reference Citation Analysis]
3 Chiang CC, Yeh CT, Hwang TL, Chu YD, Lim SN, Chen CW, Kuo CJ, Le PH, Chen TH, Lin WR. The GALNT14 Genotype Predicts Postoperative Outcome of Pancreatic Ductal Adenocarcinoma. J Clin Med 2019;8:E2225. [PMID: 31888240 DOI: 10.3390/jcm8122225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Lauc G. Precision medicine that transcends genomics: Glycans as integrators of genes and environment. Biochimica et Biophysica Acta (BBA) - General Subjects 2016;1860:1571-3. [DOI: 10.1016/j.bbagen.2016.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
5 Santos SN, Junqueira MS, Francisco G, Vilanova M, Magalhães A, Dias Baruffi M, Chammas R, Harris AL, Reis CA, Bernardes ES. O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancer. Oncotarget 2016;7:83570-87. [PMID: 27835877 DOI: 10.18632/oncotarget.13192] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
6 Kuo TC, Wu MH, Yang SH, Chen ST, Hsu TW, Jhuang JY, Liao YY, Tien YW, Huang MC. C1GALT1 high expression is associated with poor survival of patients with pancreatic ductal adenocarcinoma and promotes cell invasiveness through integrin αv. Oncogene 2021;40:1242-54. [PMID: 33420364 DOI: 10.1038/s41388-020-01594-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhou D, Xu L, Huang W, Tonn T. Epitopes of MUC1 Tandem Repeats in Cancer as Revealed by Antibody Crystallography: Toward Glycopeptide Signature-Guided Therapy. Molecules 2018;23:E1326. [PMID: 29857542 DOI: 10.3390/molecules23061326] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
8 Cao F, Gamble AB, Onagi H, Howes J, Hennessy JE, Gu C, Morgan JAM, Easton CJ. Detection of Biosynthetic Precursors, Discovery of Glycosylated Forms, and Homeostasis of Calcitonin in Human Cancer Cells. Anal Chem 2017;89:6992-9. [PMID: 28590120 DOI: 10.1021/acs.analchem.7b00457] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
9 Kurze AK, Buhs S, Eggert D, Oliveira-Ferrer L, Müller V, Niendorf A, Wagener C, Nollau P. Immature O-glycans recognized by the macrophage glycoreceptor CLEC10A (MGL) are induced by 4-hydroxy-tamoxifen, oxidative stress and DNA-damage in breast cancer cells. Cell Commun Signal 2019;17:107. [PMID: 31455323 DOI: 10.1186/s12964-019-0420-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
10 Salazar ML, Jiménez JM, Villar J, Rivera M, Báez M, Manubens A, Becker MI. N-Glycosylation of mollusk hemocyanins contributes to their structural stability and immunomodulatory properties in mammals. J Biol Chem 2019;294:19546-64. [PMID: 31719148 DOI: 10.1074/jbc.RA119.009525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
11 Matsumoto T, Okayama H, Nakajima S, Saito K, Nakano H, Endo E, Kase K, Ito M, Yamauchi N, Yamada L, Kanke Y, Onozawa H, Fujita S, Sakamoto W, Saito M, Saze Z, Momma T, Mimura K, Kono K. Tn Antigen Expression Defines an Immune Cold Subset of Mismatch-Repair Deficient Colorectal Cancer. Int J Mol Sci 2020;21:E9081. [PMID: 33260328 DOI: 10.3390/ijms21239081] [Reference Citation Analysis]
12 Schjoldager KT, Narimatsu Y, Joshi HJ, Clausen H. Global view of human protein glycosylation pathways and functions. Nat Rev Mol Cell Biol 2020;21:729-49. [PMID: 33087899 DOI: 10.1038/s41580-020-00294-x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 35.5] [Reference Citation Analysis]
13 Jeethy Ram T, Lekshmi A, Somanathan T, Sujathan K. Galectin-3: A factotum in carcinogenesis bestowing an archery for prevention. Tumour Biol 2021;43:77-96. [PMID: 33998569 DOI: 10.3233/TUB-200051] [Reference Citation Analysis]
14 Blsakova A, Kveton F, Kasak P, Tkac J. Antibodies against aberrant glycans as cancer biomarkers. Expert Rev Mol Diagn 2019;19:1057-68. [PMID: 31665948 DOI: 10.1080/14737159.2020.1687295] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Haga Y, Ueda K. Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques. Glycoconj J. [DOI: 10.1007/s10719-022-10043-1] [Reference Citation Analysis]
16 Deng B, Tarhan YE, Ueda K, Ren L, Katagiri T, Park JH, Nakamura Y. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells. Neoplasia 2018;20:1038-44. [PMID: 30208353 DOI: 10.1016/j.neo.2018.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
17 Wandall HH, Nielsen MAI, King-Smith S, de Haan N, Bagdonaite I. Global functions of O-glycosylation: promises and challenges in O-glycobiology. FEBS J 2021. [PMID: 34346177 DOI: 10.1111/febs.16148] [Reference Citation Analysis]
18 Groux-Degroote S, Foulquier F, Cavdarli S, Delannoy P. [Reticular and Golgi glycosylation: Advances and associated diseases]. Med Sci (Paris) 2021;37:609-17. [PMID: 34180820 DOI: 10.1051/medsci/2021082] [Reference Citation Analysis]
19 Weidle UH, Brinkmann U, Auslaender S. microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical In Vivo Models. Cancer Genomics Proteomics 2020;17:453-68. [PMID: 32859626 DOI: 10.21873/cgp.20204] [Reference Citation Analysis]
20 Wen L, Liu D, Zheng Y, Huang K, Cao X, Song J, Wang PG. A One-Step Chemoenzymatic Labeling Strategy for Probing Sialylated Thomsen-Friedenreich Antigen. ACS Cent Sci 2018;4:451-7. [PMID: 29721527 DOI: 10.1021/acscentsci.7b00573] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 9.8] [Reference Citation Analysis]
21 Riedl B, Schmid W. A stereoselective and flexible synthesis to access both enantiomers of N-acetylgalactosamine and peracetylated N-acetylidosamine. Beilstein J Org Chem 2018;14:856-60. [PMID: 29719580 DOI: 10.3762/bjoc.14.71] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Deng Z, Yi X, Chu J, Zhuang Y. A study on enhanced O-glycosylation strategy for improved production of recombinant human chorionic gonadotropin in Chinese hamster ovary cells. J Biotechnol 2019;306:159-68. [PMID: 31604106 DOI: 10.1016/j.jbiotec.2019.10.006] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Steentoft C, Fuhrmann M, Battisti F, Van Coillie J, Madsen TD, Campos D, Halim A, Vakhrushev SY, Joshi HJ, Schreiber H, Mandel U, Narimatsu Y. A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody. Glycobiology 2019;29:307-19. [PMID: 30726901 DOI: 10.1093/glycob/cwz004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
24 Guillen-Poza PA, Sánchez-Fernández EM, Artigas G, García Fernández JM, Hinou H, Ortiz Mellet C, Nishimura SI, Garcia-Martin F. Amplified Detection of Breast Cancer Autoantibodies Using MUC1-Based Tn Antigen Mimics. J Med Chem 2020;63:8524-33. [PMID: 32672464 DOI: 10.1021/acs.jmedchem.0c00908] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Yao X, Ajani JA, Song S. Molecular biology and immunology of gastric cancer peritoneal metastasis. Transl Gastroenterol Hepatol 2020;5:57. [PMID: 33073052 DOI: 10.21037/tgh.2020.02.08] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Boottanun P, Ino Y, Shimada K, Hiraoka N, Angata K, Narimatsu H. Association between the expression of core 3 synthase and survival outcomes of patients with cholangiocarcinoma. Oncol Lett 2021;22:760. [PMID: 34539864 DOI: 10.3892/ol.2021.13021] [Reference Citation Analysis]
27 Cagnoni AJ, Pérez Sáez JM, Rabinovich GA, Mariño KV. Turning-Off Signaling by Siglecs, Selectins, and Galectins: Chemical Inhibition of Glycan-Dependent Interactions in Cancer. Front Oncol 2016;6:109. [PMID: 27242953 DOI: 10.3389/fonc.2016.00109] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 9.2] [Reference Citation Analysis]
28 Liu HM, Ma LL, Cao B, Lin JZ, Han L, Li CY, Xu RC, Zhang DK. Progress in research into the role of abnormal glycosylation modification in tumor immunity. Immunol Lett 2021;229:8-17. [PMID: 33186635 DOI: 10.1016/j.imlet.2020.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Tikhonov A, Smoldovskaya O, Feyzkhanova G, Kushlinskii N, Rubina A. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications. Clin Chem Lab Med 2020;58:1611-22. [PMID: 32324152 DOI: 10.1515/cclm-2019-1161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
30 Matsumoto Y, Kudelka MR, Hanes MS, Lehoux S, Dutta S, Jones MB, Stackhouse KA, Cervoni GE, Heimburg-Molinaro J, Smith DF, Ju T, Chaikof EL, Cummings RD. Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies. Glycobiology 2020;30:282-300. [PMID: 31742337 DOI: 10.1093/glycob/cwz095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yang W, Ao M, Hu Y, Li QK, Zhang H. Mapping the O-glycoproteome using site-specific extraction of O-linked glycopeptides (EXoO). Mol Syst Biol 2018;14:e8486. [PMID: 30459171 DOI: 10.15252/msb.20188486] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 16.3] [Reference Citation Analysis]
32 Gao H, Zheng M, Sun S, Wang H, Yue Z, Zhu Y, Han X, Yang J, Zhou Y, Cai Y, Hu W. Chaperonin containing TCP1 subunit 5 is a tumor associated antigen of non-small cell lung cancer. Oncotarget 2017;8:64170-9. [PMID: 28969060 DOI: 10.18632/oncotarget.19369] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
33 Turupcu A, Diem M, Smith LJ, Oostenbrink C. Structural Aspects of the O-glycosylation Linkage in Glycopeptides via MD Simulations and Comparison with NMR Experiments. Chemphyschem 2019;20:1527-37. [PMID: 30920077 DOI: 10.1002/cphc.201900079] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
34 Xu S, Zheng J, Xiao H, Wu R. Simultaneously Identifying and Distinguishing Glycoproteins with O-GlcNAc and O-GalNAc (the Tn Antigen) in Human Cancer Cells. Anal Chem 2022. [PMID: 35132862 DOI: 10.1021/acs.analchem.1c05438] [Reference Citation Analysis]
35 Ros M, Nguyen AT, Chia J, Le Tran S, Le Guezennec X, McDowall R, Vakhrushev S, Clausen H, Humphries MJ, Saltel F, Bard FA. ER-resident oxidoreductases are glycosylated and trafficked to the cell surface to promote matrix degradation by tumour cells. Nat Cell Biol 2020;22:1371-81. [PMID: 33077910 DOI: 10.1038/s41556-020-00590-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
36 Prasher P, Sharma M. Medicinal chemistry of pyrophosphate mimics: A mini review. Drug Dev Res 2021. [PMID: 34506652 DOI: 10.1002/ddr.21877] [Reference Citation Analysis]
37 Cote R, Lynn Eggink L, Kenneth Hoober J; Susavion Biosciences, Inc., 1615 W. University Drive, Suite 132, Tempe, AZ 85281, USA. . AIMS Allergy and Immunology 2017;1:207-31. [DOI: 10.3934/allergy.2017.4.207] [Cited by in Crossref: 6] [Article Influence: 1.2] [Reference Citation Analysis]
38 Kotsias M, Kozak RP, Gardner RA, Wuhrer M, Spencer DIR. Improved and semi-automated reductive β-elimination workflow for higher throughput protein O-glycosylation analysis. PLoS One 2019;14:e0210759. [PMID: 30653606 DOI: 10.1371/journal.pone.0210759] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
39 Eggink LL, Roby KF, Cote R, Kenneth Hoober J. An innovative immunotherapeutic strategy for ovarian cancer: CLEC10A and glycomimetic peptides. J Immunother Cancer 2018;6:28. [PMID: 29665849 DOI: 10.1186/s40425-018-0339-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
40 Supruniuk K, Czarnomysy R, Muszyńska A, Radziejewska I. Combined Action of Anti-MUC1 Monoclonal Antibody and Pyrazole-Platinum(II) Complexes Reveals Higher Effectiveness towards Apoptotic Response in Comparison with Monotherapy in AGS Gastric Cancer Cells. Pharmaceutics 2021;13:968. [PMID: 34206951 DOI: 10.3390/pharmaceutics13070968] [Reference Citation Analysis]
41 Guo Y, Shi J, Zhang J, Li H, Liu B, Guo H. Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer. Onco Targets Ther 2017;10:3337-44. [PMID: 28744137 DOI: 10.2147/OTT.S138590] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
42 Krishnan S, Whitwell HJ, Cuenco J, Gentry-Maharaj A, Menon U, Pereira SP, Gaspari M, Timms JF. Evidence of Altered Glycosylation of Serum Proteins Prior to Pancreatic Cancer Diagnosis. Int J Mol Sci. 2017;18. [PMID: 29232830 DOI: 10.3390/ijms18122670] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
43 Polei M, Günther J, Koczan D, Fürbass R. Trophoblast cell differentiation in the bovine placenta: differentially expressed genes between uninucleate trophoblast cells and trophoblast giant cells are involved in the composition and remodeling of the extracellular matrix and O-glycan biosynthesis. BMC Mol Cell Biol 2020;21:1. [PMID: 31952476 DOI: 10.1186/s12860-020-0246-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
44 Suttapitugsakul S, Sun F, Wu R. Recent Advances in Glycoproteomic Analysis by Mass Spectrometry. Anal Chem 2020;92:267-91. [PMID: 31626732 DOI: 10.1021/acs.analchem.9b04651] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 13.3] [Reference Citation Analysis]
45 Shen B, Zhang W, Shi Z, Tian F, Deng Y, Sun C, Wang G, Qin W, Qian X. A novel strategy for global mapping of O-GlcNAc proteins and peptides using selective enzymatic deglycosylation, HILIC enrichment and mass spectrometry identification. Talanta 2017;169:195-202. [PMID: 28411811 DOI: 10.1016/j.talanta.2017.03.049] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
46 Arend P. Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM). Cancer Med 2017;6:1601-13. [PMID: 28580709 DOI: 10.1002/cam4.1079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
47 Fujita K, Iwama H, Oura K, Tadokoro T, Samukawa E, Sakamoto T, Nomura T, Tani J, Yoneyama H, Morishita A, Himoto T, Hirashima M, Masaki T. Cancer Therapy Due to Apoptosis: Galectin-9. Int J Mol Sci 2017;18:E74. [PMID: 28045432 DOI: 10.3390/ijms18010074] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
48 Kurfiřt M, Lucie ČŠ, Cuřínová P, Hamala V, Karban J. Development of α-Selective Glycosylation for the Synthesis of Deoxyfluorinated T N Antigen Analogues. J Org Chem 2021;86:5073-90. [DOI: 10.1021/acs.joc.0c03015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Cornelissen LA, Van Vliet SJ. A Bitter Sweet Symphony: Immune Responses to Altered O-glycan Epitopes in Cancer. Biomolecules 2016;6:E26. [PMID: 27153100 DOI: 10.3390/biom6020026] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 4.2] [Reference Citation Analysis]
50 Hoja-Łukowicz D, Szwed S, Laidler P, Lityńska A. Proteomic analysis of Tn-bearing glycoproteins from different stages of melanoma cells reveals new biomarkers. Biochimie 2018;151:14-26. [PMID: 29802864 DOI: 10.1016/j.biochi.2018.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
51 Raghu D, Mobley RJ, Shendy NAM, Perry CH, Abell AN. GALNT3 Maintains the Epithelial State in Trophoblast Stem Cells. Cell Rep 2019;26:3684-3697.e7. [PMID: 30917321 DOI: 10.1016/j.celrep.2019.02.093] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
52 Gao Z, Xu M, Yue S, Shan H, Xia J, Jiang J, Yang S. Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers. Curr Res Pharmacol Drug Discov 2022;3:100079. [PMID: 35005612 DOI: 10.1016/j.crphar.2021.100079] [Reference Citation Analysis]
53 Kaur I, Ruskamo S, Koivunen J, Heljasvaara R, Lackman JJ, Izzi V, Petäjä-Repo UE, Kursula P, Pihlajaniemi T. The N-terminal domain of unknown function (DUF959) in collagen XVIII is intrinsically disordered and highly O-glycosylated. Biochem J 2018;475:3577-93. [PMID: 30327321 DOI: 10.1042/BCJ20180405] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
54 Rømer TB, Aasted MKM, Dabelsteen S, Groen A, Schnabel J, Tan E, Pedersen JW, Haue AD, Wandall HH. Mapping of truncated O-glycans in cancers of epithelial and non-epithelial origin. Br J Cancer 2021;125:1239-50. [PMID: 34526666 DOI: 10.1038/s41416-021-01530-7] [Reference Citation Analysis]
55 Liu Z, Liu J, Dong X, Hu X, Jiang Y, Li L, Du T, Yang L, Wen T, An G, Feng G. Tn antigen promotes human colorectal cancer metastasis via H-Ras mediated epithelial-mesenchymal transition activation. J Cell Mol Med. 2019;23:2083-2092. [PMID: 30637914 DOI: 10.1111/jcmm.14117] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
56 Beckwith DM, Cudic M. Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design. Semin Immunol 2020;47:101389. [PMID: 31926647 DOI: 10.1016/j.smim.2020.101389] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
57 Blanas A, Cornelissen LAM, Kotsias M, van der Horst JC, van de Vrugt HJ, Kalay H, Spencer DIR, Kozak RP, van Vliet SJ. Transcriptional activation of fucosyltransferase (FUT) genes using the CRISPR-dCas9-VPR technology reveals potent N-glycome alterations in colorectal cancer cells. Glycobiology. 2019;29:137-150. [PMID: 30476078 DOI: 10.1093/glycob/cwy096] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
58 de Oliveira RM, Ornelas Ricart CA, Araujo Martins AM. Use of Mass Spectrometry to Screen Glycan Early Markers in Hepatocellular Carcinoma. Front Oncol. 2017;7:328. [PMID: 29379771 DOI: 10.3389/fonc.2017.00328] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
59 Prasher P, Sharma M. Targeting N-acetylgalactosaminyltransferase for anticancer therapy. Drug Dev Res 2021;82:3-6. [PMID: 32985012 DOI: 10.1002/ddr.21744] [Reference Citation Analysis]
60 Valoskova K, Biebl J, Roblek M, Emtenani S, Gyoergy A, Misova M, Ratheesh A, Reis-Rodrigues P, Shkarina K, Larsen ISB, Vakhrushev SY, Clausen H, Siekhaus DE. A conserved major facilitator superfamily member orchestrates a subset of O-glycosylation to aid macrophage tissue invasion. Elife 2019;8:e41801. [PMID: 30910009 DOI: 10.7554/eLife.41801] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]